Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016)

Insight Molecular Diagnostics (IMDX) posted Current Taxes of $151000.0 for Q4 2016, little changed sequentially from $151000.0 in Q3 2016, and up 277.5% YoY from $40000.0 in Q1 2016.

Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016) Analysis & Trends

Insight Molecular Diagnostics has reported Current Taxes for 2 years, with the latest figure at $151000.0 in Q4 2016.

  • Quarterly Current Taxes rose 277.5% year-over-year to $151000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $151000.0 (up 277.5% YoY) and the FY2016 annual result came in at $151000.0, up 277.5% from the prior year.
  • Current Taxes held at $151000.0 in Q4 2016 per IMDX's latest filing, from $151000.0 in the prior quarter.
  • Over five years, Current Taxes peaked at $151000.0 in Q2 2016 and troughed at $40000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn -
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn -
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn -
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn -
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn 175.00 Mn
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn -
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn -
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn 188.49 Mn
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn -
10 Insight Molecular Diagnostics 172.42 Mn 143.49 Mn 15,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2016 151,000.00
Sep 30, 2016 151,000.00
Jun 30, 2016 151,000.00
Dec 31, 2015 40,000.00